SLITRK4 and neoplasm: Consistent with the observation in vitro, when SLITRK4‐knockdown SW620 cells were implanted, the tumor growth rate was slower than that of the control in vivo, otherwise, SLITRK4 overexpression resulted in significantly higher proliferation (Figure 2g,h).